The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter.
Methylmercury (MeHg) is a potent neurotoxin. The mechanism(s) that governs MeHg transport across the blood-brain barrier and other biological membranes remains unclear. This study addressed the role of the L-type large neutral amino acid transporter, LAT1, in MeHg transport. Studies were carried out in CHO-k1 cells. Over-expression of LAT1 in these cells was associated with enhanced uptake of [(14)C]-MeHg when treated with L-cysteine, but not with the D-cysteine conjugate. In the presence of excess L-methionine, a substrate for LAT1, L-cysteine-conjugated [(14)C]-MeHg uptake was significantly attenuated. Treatment of LAT-1 over-expressing CHO-k1 cells with L-cysteine-conjugated MeHg was also associated with increased leakage of lactate dehydrogenase into the media as well as reduced cell viability measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assay. In contrast, knock-down of LAT1 decreased the uptake of l-cysteine-conjugated MeHg and attenuated the effects of MeHg on lactate dehydrogenase leakage and CHO-k1 cell viability. These results indicate that the MeHg-L-cysteine conjugate is a substrate for the neutral amino acid transporter, LAT1, which actively transports MeHg across membranes.
Yin
Zhaobao
Z
Department of Pediatrics, Kennedy Center for Research on human Development, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Jiang
Haiyan
H
Syversen
Tore
T
Rocha
João B T
JB
Farina
Marcelo
M
Aschner
Michael
M
D000704:Analysis of Variance; D000818:Animals; D016466:CHO Cells; D002247:Carbon Isotopes / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D006224:Cricetinae; D003412:Cricetulus; D003545:Cysteine / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D027283:Large Neutral Amino Acid-Transporter 1 / Q000235:genetics / Q000378:metabolism*; D008767:Methylmercury Compounds / Q000378:metabolism* / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000494:pharmacology; D013778:Tetrazolium Salts; D013844:Thiazoles; D014162:Transfection / Q000379:methods
D002247:Carbon Isotopes; D027283:Large Neutral Amino Acid-Transporter 1; D008767:Methylmercury Compounds; D034741:RNA, Small Interfering; D013778:Tetrazolium Salts; D013844:Thiazoles; D007770:L-Lactate Dehydrogenase; C022616:thiazolyl blue; D003545:Cysteine
Am J Physiol. 1971 Dec;221(6):1629-39
5124307
Environ Res. 1995 Jul;70(1):47-50
8603658
Toxicol Appl Pharmacol. 1980 Sep 15;55(2):318-23
7423520
Annu Rev Pharmacol Toxicol. 1993;33:545-71
8494351
Brain Res. 1988 Oct 11;462(1):31-9
3179736
J Biol Chem. 1998 Sep 11;273(37):23629-32
9726963
Nature. 1998 Sep 17;395(6699):288-91
9751058
Neuroreport. 2000 Nov 9;11(16):3507-11
11095508
Pflugers Arch. 2003 Feb;445(5):529-33
12634921
Toxicol Sci. 2007 Jun;97(2):428-37
17204583
Neurotoxicology. 2008 May;29(3):453-9
18400302
Brain Res. 1990 Jun 25;521(1-2):221-8
2207661
J Biol Chem. 1999 Jan 29;274(5):3009-16
9915839
Biochem J. 1972 Nov;130(2):61P-63P
4677142
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12079-84
10518579
J Cereb Blood Flow Metab. 2000 Nov;20(11):1557-62
11083230
J Biol Chem. 2003 Oct 31;278(44):43838-45
12930836
Arch Toxicol. 1996;70(5):310-4
8852703
J Biol Chem. 1999 Jul 9;274(28):19745-51
10391916
Pharmacol Toxicol. 1989 Jul;65(1):17-20
2780503
Reprod Toxicol. 2007 Apr-May;23(3):414-20
17408921
Ann N Y Acad Sci. 1957 Apr 11;65(5):454-60
13411943
Environ Health Perspect. 2002 Oct;110 Suppl 5:689-94
12426113
Pharmacol Toxicol. 1989 Mar;64(3):293-7
2498864
Toxicol Appl Pharmacol. 2005 May 1;204(3):274-308
15845419
Toxicol Sci. 2004 Sep;81(1):172-8
15201443
Neurotoxicol Teratol. 2006 May-Jun;28(3):363-75
16647838
J Pharmacol Exp Ther. 1995 Mar;272(3):1277-84
7891344
Pediatr Res. 2004 Apr;55(4):557-60
14764922
Physiol Rev. 1990 Jan;70(1):43-77
2404290
Neurotoxicology. 1998 Apr;19(2):313-28
9553968
Glia. 2002 Oct;40(1):85-94
12237846
Biochem J. 2002 Oct 1;367(Pt 1):239-46
12117417
Neurosci Lett. 2001 Jun 22;306(1-2):1-4
11403943
Toxicol Appl Pharmacol. 1982 Jan;62(1):104-10
7064146
J Neurochem. 2006 Apr;97(1):69-78
16524380
Biochem Biophys Res Commun. 1999 Feb 16;255(2):283-8
10049700
J Neurol Sci. 2007 Nov 15;262(1-2):131-44
17681548
Environ Res. 1999 Apr;80(3):208-14
10092441
Am J Physiol. 1992 May;262(5 Pt 2):R761-5
1590471
Science. 1973 Jul 20;181(4096):230-41
4719063
Mol Pharmacol. 2002 Apr;61(4):729-37
11901210
Annu Rev Pharmacol Toxicol. 2004;44:87-110
14744240
Science. 2000 Feb 25;287(5457):1433-8
10688783
Nature. 1963 Feb 23;197:765-7
13940861
J Neurochem. 2007 Dec;103(5):1968-81
17760861
Neuroreport. 2000 Nov 27;11(17):3663-6
11117468
J Biol Chem. 1999 Jul 9;274(28):19738-44
10391915
J Biol Chem. 2005 Mar 25;280(12):12002-11
15659399
Biochim Biophys Acta. 2001 Oct 1;1514(2):291-302
11557028
EMBO J. 2002 Feb 15;21(4):580-9
11847106
Pharmacogenet Genomics. 2007 Jul;17(7):505-17
17558306